| Literature DB >> 29997306 |
Tianliang Zhang1,2,3, Haotai Chen4,5, Linlin Qi6,7, Jie Zhang8,9, Run Wu10, Yongguang Zhang11,12, Yuefeng Sun13,14.
Abstract
Foot-and-mouth disease (FMD) is a highly contagious disease that results in enormous economic loses worldwide. Although the protection provided by vaccination is limited during early infection, it is recognized as the best method to prevent FMD outbreaks. Furthermore, the mechanism of host early responses against foot-and-mouth disease virus (FMDV) infection remains unclear. In our study, a pig kidney cell line (PK-15) was used as a cell model to reveal the mechanism of early pig responses to FMDV infection. Four non-treated control and four FMDV-treated PK-15 cells were sequenced with RNA-seq technology, and the differentially expressed genes (DEGs) were analyzed. The results showed that 1212 DEGs were in the FMDV-infected PK-15 cells, including 914 up-regulated and 298 down-regulated genes. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were significantly enriched in the tumor necrosis factor (TNF), cytokine-cytokine receptor interaction, NOD-like receptor, toll-like receptor, NF-κB, and the chemokine signaling pathways. To verify the results of the DEGs, 30 immune-related DEGs (19 up-regulated and 11 down-regulated) were selected for Quantitative Reverse Transcriptase polymerase chain reaction (RT-qPCR) verification. The results showed that RT-qPCR-measured genes exhibited a similar pattern as the RNA-seq analyses. Based on bioinformatics analysis, during FMDV early infection, we found that a series of cytokines, such as interleukins (IL6), chemokines (CXCL2, CCL20 and CCL4), and transcription factors (ZFP36, FOS, NFKBIA, ZBTB3, ZNF503, ZNF283, dymeclin (DYM), and orthodenticle homeobox 1 (OTX1)) were involved in the battle between FMDV and the host. Combined with their features and functions, we propose inflammation as the main early mechanism by which the host responds to FMDV infection. These data provide an additional panel of candidate genes for deciphering the mechanisms of a host's early response against FMDV infection.Entities:
Keywords: FMDV; PK-15 cells; RNA-seq; RT-qPCR; inflammation
Mesh:
Year: 2018 PMID: 29997306 PMCID: PMC6071144 DOI: 10.3390/v10070364
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Results of data filtering statistics.
| Sample | Number of Raw Reads | Raw Bases | Number of Clean Reads | Clean Bases | Clean Rate (%) | Q20 (%) | Q30 (%) |
|---|---|---|---|---|---|---|---|
| NC1 | 69,947,474 | 10,471,100,044 | 66,625,990 | 9,975,061,999 | 95.25 | 97.36 | 93.02 |
| NC2 | 73,866,982 | 11,049,947,666 | 70,335,908 | 10,522,323,451 | 95.22 | 97.4 | 93.11 |
| NC3 | 81,300,244 | 12,158,932,746 | 77,781,474 | 11,633,597,601 | 95.67 | 97.58 | 93.49 |
| NC4 | 81,147,108 | 12,142,577,269 | 77,706,416 | 11,629,317,726 | 95.76 | 97.58 | 93.51 |
| FMDV1 | 78,462,120 | 11,740,662,522 | 74,801,356 | 11,193,766,188 | 95.33 | 97.53 | 93.4 |
| FMDV2 | 72,232,906 | 10,805,776,246 | 68,752,730 | 10,285,816,296 | 95.18 | 97.44 | 93.22 |
| FMDV3 | 106,781,936 | 15,980,867,239 | 98,827,180 | 14,792,807,205 | 92.55 | 97.11 | 92.11 |
| FMDV4 | 108,452,172 | 16,218,870,628 | 100,499,600 | 15,030,783,309 | 92.67 | 97.15 | 92.21 |
Alignment results.
| Samples | Total Reads | Mapped Reads | Uniquely Mapped Reads | Multiple Mapped Reads |
|---|---|---|---|---|
| NC1 | 66,625,990 (100.00%) | 52,009,891 (78.06%) | 46,518,117 (89.44%) | 5,491,774 (10.56%) |
| NC2 | 70,335,908 (100.00%) | 54,883,603 (78.03%) | 49,189,786 (89.63%) | 5,693,817 (10.37%) |
| NC3 | 77,781,474 (100.00%) | 60,847,412 (78.23%) | 54,541,968 (89.64%) | 6,305,444 (10.36%) |
| NC4 | 77,706,416 (100.00%) | 60,412,369 (77.74%) | 54,154,641 (89.64%) | 6,257,728 (10.36%) |
| FMDV1 | 74,801,356 (100.00%) | 57,611,053 (77.02%) | 51,467,860 (89.34%) | 6,143,193 (10.66%) |
| FMDV2 | 68,752,730 (100.00%) | 52,393,703 (76.21%) | 46,872,931 (89.46%) | 5,520,772 (10.54%) |
| FMDV3 | 98,827,180 (100.00%) | 75,927,134 (76.83%) | 67,639,000 (89.08%) | 8,288,134 (10.92%) |
| FMDV4 | 100,499,600 (100.00%) | 77,810,999 (77.42%) | 69,128,894 (88.84%) | 8,682,105 (11.16%) |
Assembled results.
| Sample | Gene Number | Transcript Number | Exon Total Length (bp) | Average Transcript Length (bp) | Max. Transcript Length (bp) | Min. Transcript Length (bp) | N50 Length (bp, without Intron) |
|---|---|---|---|---|---|---|---|
| NC1 | 25,335 | 33,078 | 67,074,593 | 2028 | 24,882 | 156 | 2849 |
| NC2 | 25,818 | 33,561 | 68,649,462 | 2046 | 25,217 | 155 | 2875 |
| NC3 | 26,538 | 34,605 | 71,034,457 | 2053 | 25,181 | 140 | 2900 |
| NC4 | 27,077 | 35,203 | 71,479,661 | 2030 | 24,449 | 149 | 2859 |
| FMDV1 | 25,299 | 33,123 | 66,066,603 | 1995 | 25,261 | 122 | 2814 |
| FMDV2 | 25,499 | 33,311 | 65,027,535 | 1952 | 19,333 | 148 | 2769 |
| FMDV3 | 28,927 | 37,145 | 73,142,162 | 1969 | 22,369 | 141 | 2872 |
| FMDV4 | 29,472 | 37,785 | 73,269,692 | 1939 | 25,126 | 143 | 2839 |
| cuffmerge | 28,141 | 72,673 | 213,510,612 | 2938 | 26,354 | 129 | 4259 |
Figure 1Quality control and statistics of differentially expressed genes (DEGs). (A) Length distribution of the assembled transcript, where the x-axis represents the length distribution and the y-axis indicates the number of transcripts at each length. More than 25,000 transcripts had a length equal to or greater than 3000, which was the largest proportion. (B) Sample correlation heat map. The green to red color key indicates the Pearson correlation coefficient (R) value, representing lower to higher r-values, respectively, suggesting the sample repeatability in the same group and also reflecting the differences between the two groups. (C) Number of differential genes between foot-and-mouth disease virus (FMDV)-treated and non-treated groups. Red represents up-regulated genes and green represents down-regulated genes. The y-axis indicates the number of genes. (D) Volcano plots of the distribution of DEGs. The x-axis indicates the fold changes of DEGs; the greater the absolute x-value, the greater the fold change. The y-axis represents the significance of the DEGs; the greater the y-value, the smaller the p-value. Red dots represent up-regulated genes, green dots represent down-regulated genes, and black dots represent not significantly regulated genes.
Figure 2Gene ontology (GO) functional classification and enrichment analysis of DEGs. (A) GO functional classification of the DEGs. The x-axis indicates the functional description of the GO classifications, the left y-axis represents the proportion of the number of genes annotated to the GO database in the number of background genes, and the right y-axis represents the number of genes. The solid line represents the number of DEGs and the dotted line represents the total number of genes expressed in the background. All GO terms are grouped into three major categories: Blue is for biological processes, green is for cellular components, and red is for molecular function. A total of 2270 DEGs were classified to the unique gene matches, including 1375 DEGs (60.6%) to biological processes, 651 DEGs (28.7%) to cellular components, and 244 DEGs (10.7%) to molecular function. (B) Top 30 GO enrichment results of DEGs. The x-axis indicates –log (corrected p-value). A greater x-value represents a smaller corrected p-value, suggesting the enrichment is more significant. The y-axis represents the function descriptions of the GO terms. The regulation of metabolic processes is the most significant enriched GO term, followed by regulation of primary metabolic processes, regulation of cellular metabolic processes, and so forth.
Figure 3Kyoto Encyclopedia of Genes and Genomes (KEGG) classifications and pathway enrichment analysis of DEGs. (A) KEGG classifications of DEGs. The x-axis indicates the number of DEGs and the y-axis represents KEGG terms. All KEGG terms are grouped into seven categories: dark yellow is for cellular processes, red is for drug development, purple is for environmental information processing, light blue is for genetic information processing, light yellow is for human diseases, light red is for metabolism, and green is for organismal systems. (B) Top 30 pathway enrichment results for the DEGs. The x-axis indicates the –log (corrected p-value). The greater the x-value, the smaller the corrected p-value, suggesting the enrichment is more significant. The y-axis represents the function descriptions of the enriched pathways. The TNF signaling pathway is the most significant enriched pathway, followed by salmonella infection, rheumatoid arthritis, cytokine-cytokine receptor interaction, NOD-like receptor signaling pathway, toll-like receptor signaling pathway, NF-kappa B signaling pathway, and the chemokine signaling pathway.
Gene ontology (GO) analysis of immune-related DEGs.
| GO ID | Category | Gene Number | Representative Genes |
|---|---|---|---|
| GO:0002376 | immune system process | 39 | HOXB6, EPHA2, IL6, CCL5, SOCS1, IRF1, TNFRSF4, CD83, EGR1, IL1A, ZFP36L1, BATF2, CHST3, CSF2, TNF, ADM, CEBPE, CXCL2, SOX9, LIF, ULBP1, EGR3, PHLPP1, CCR7, MAP3K14, CDC37, TNFSF15, CD70, ITPKC, NFKBIA, NR4A3, CCL4, NFIL3 |
| GO:0006955 | immune response | 26 | CSF2, ADM, TNF, CXCL2, IL6, CCL5, LIF, ULBP1, CCR7, MAP3K14, SOCS1, TNFRSF4, IRF1, TNFSF15, CDC37, CD70, NFKBIA, CCL4, IL1A, NR4A3, NFIL3 |
| GO:0002682 | regulation of immune system process | 19 | TNF, SOX9, CCL5, LIF, EGR3, CCR7, PHLPP1, SOCS1, IRF1, CDC37, CD83, ITPKC, NFKBIA, NR4A3, CHST3 |
| GO:0002520 | immune system development | 16 | EPHA2, TNF, CEBPE, IL6, LIF, EGR3, CCR7, PHLPP1, IRF1, CD83, EGR1, NFKBIA, ZFP36L1, BATF2 |
| GO:0002684 | positive regulation of immune system process | 12 | IRF1, CD83, TNF, NFKBIA, CCL5, NR4A3, LIF, EGR3, CCR |
| GO:0045088 | regulation of innate immune response | 4 | NFKBIA, SOCS1, IRF1, CDC37 |
| GO:0050776 | regulation of immune response | 7 | NFKBIA, SOCS1, NR4A3, IRF1, CDC37, CCR7, TNF |
| GO:0002683 | negative regulation of immune system process | 5 | SOX9, NFKBIA, IRF1, TNF |
| GO:0002253 | activation of immune response | 4 | NFKBIA, NR4A3, IRF1, CCR7 |
| GO:0002252 | immune effector process | 8 | IRF1, TNF, ITPKC, NR4A3, IL6, ULBP1, CHST3 |
| GO:0050778 | positive regulation of immune response | 5 | NFKBIA, NR4A3, IRF1, CCR7, TNF |
| GO:0045087 | innate immune response | 7 | NFKBIA, SOCS1, CCL5, CCL4, IRF1, ULBP1, CDC37 |
| GO:0002218 | activation of innate immune response | 2 | NFKBIA, IRF1 |
| GO:0002697 | regulation of immune effector process | 4 | ITPKC, NR4A3, CHST3, TNF |
| GO:0002366 | leukocyte activation involved in immune response | 3 | IL6, NR4A3 |
| GO:0045089 | positive regulation of innate immune response | 2 | NFKBIA, IRF1 |
| GO:0002521 | leukocyte differentiation | 13 | EPHA2, IRF1, CD83, TNF, CEBPE, EGR1, IL6, LIF, ZFP36L1, BATF2, EGR3, CCR7 |
| GO:0097529 | myeloid leukocyte migration | 6 | CCL5, CCL4, CCR7 |
| GO:0007159 | leukocyte cell-cell adhesion | 11 | IRF1, CD83, TNF, EGR1, NR4A3, CCL5, IL6, ZFP36L1, EGR3, CCR7 |
| GO:0045321 | leukocyte activation | 13 | IRF1, CD83, EGR1, IL6, NR4A3, CCL5, ZFP36L1, BATF2, EGR3, CCR7 |
| GO:0050900 | leukocyte migration | 7 | CCL5, CCL4, CCR7, TNF |
| GO:0002274 | myeloid leukocyte activation | 5 | CCL5, NR4A3, BATF2 |
| GO:0070486 | leukocyte aggregation | 10 | IRF1, CD83, EGR1, NR4A3, CCL5, IL6, ZFP36L1, EGR3, CCR7 |
Figure 4Verification of RNA-seq-detected DEGs with RT-qPCR. PK-15 cells were infected with FMDV (MOI 0.1) for 1 h and then RT-qPCR was performed to detect the relative expression of selected DEGs. The x-axis indicates the names of detected genes and the y-axis represents the fold changes after FMDV infection, β-Actin was used as an internal control.